About
Pressroom
Resources
Get Updates
Issues
Access to Medicines
Funding the Fight
Health Justice
Transparency & Accountability
PEPFAR Watch
Blog
Our Impact
Take Action
Do something now
DONATE
December 2, 2024 |
Asia Russell
Gilead under fire over HIV drug licensing deals
Gilead under fire over HIV drug licensing deals
Gilead licenses generic version of Lenacapavir as PREP in 120 countries outside the U.S.
A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
Related Posts
Access to Medicines
Pharma’s alleged “brea...
PEPFAR Watch
PEPFAR is Rolling the Cloc...
Access to Medicines
Pharma Pricing Secrecy Run...
